| 1 |
21666702 | Effects of ticlopidine on pharmacokinetics of losartan and its main metabolite EXP-3174 in rats. | 2011 Jul |
2 |
| 2 |
18474675 | Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. | 2008 Aug |
1 |
| 3 |
17307149 | 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. | 2007 Apr 6 |
1 |
| 4 |
11181505 | Metabolic characterization of the major human small intestinal cytochrome p450s. | 2001 Mar |
1 |
| 5 |
11580286 | Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. | 2001 Oct 9 |
2 |
| 6 |
10759690 | In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. | 2000 Apr |
1 |
| 7 |
9390115 | Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19. | 1997 Nov |
1 |